Rule 8.3 - INVERNESS MEDICAL INNOVATIONS INC
FORM 8.3
DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
(Rule 8.3 of the City Code on Takeovers and Mergers)
1. KEY INFORMATION
Name of person dealing BARCLAYS PLC
(Note 1)
Company dealt in INVERNESS MEDICAL INNOVATIONS INC
Class of relevant security COM STK USD0.001
to which the dealings being
disclosed relate (Note 2)
Date of dealing 30 June 2009
2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
(1) Relevant 2,160,353 2.74% 116,090 0.15%
securities
(2) Derivatives 0 0.00%
(other than
options)
(3) Options and 170,400 0.22% 52,700 0.07%
agreements to
purchase/sell
Total 2,330,753 2.96% 168,790 0.21%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of Long Short
relevant
security:
Number (%) Number (%)
(1) Relevant
securities
(2) Derivatives
(other than
options)
(3) Options and
agreements to
purchase/sell
Total
(c) Rights to subscribe (Note 3)
Class of relevant security: Details
3. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of Securities Price per unit
(GBP)
Purchase 1,383 35.4798 USD
Purchase 1,122 35.11605615
Purchase 946 35.5800 USD
Purchase 400 35.6742
Purchase 100 35.67
Purchase 100 35.8
Purchase 1,119 35.5800 USD
Purchase 100 35.77
Purchase 350 35.62871429
Purchase 100 35.71
Purchase 1,203 35.5800 USD
Purchase 1,203 35.4983 USD
Purchase 530 35.5800 USD
Purchase 1,383 35.5800 USD
Purchase 708 35.5800 USD
Purchase 12 35.5800 USD
Purchase 2,389 35.5800 USD
Purchase 5,269 35.5800 USD
Purchase 7,479 35.5800 USD
Purchase 50 35.4635
Purchase 238 35.58
Purchase 300 35.596
Purchase 100 35.456
Purchase 3,540 35.58
Purchase 1,600 35.4536
Purchase 600 35.456
Purchase 1,368 35.5800 USD
Purchase 1,635 35.50948012
Purchase 200 35.68375
Purchase 100 35.455
Purchase 200 35.535
Purchase 300 35.57133333
Purchase 56 35.5800 USD
Purchase 500 35.5230 USD
Purchase 300 35.48
Purchase 300 35.51
Purchase 360 35.355
Purchase 700 35.40714286
Purchase 305 35.48885246
Purchase 106 35.5800 USD
Purchase 129 35.5800 USD
Purchase 130 35.5800 USD
Purchase 13,000 35.4469
Purchase 189 35.5800 USD
Purchase 499 35.5800 USD
Purchase 100 35.17
Purchase 637 35.65610675
Sale 44 35.5800 USD
Sale 53 35.5800 USD
Sale 22 35.5800 USD
Sale 2,389 35.5800 USD
Sale 1,454 35.5800 USD
Sale 77 35.5800 USD
Sale 1,000 35.5800 USD
Sale 84 35.5800 USD
Sale 1,224 35.5800 USD
Sale 1,203 35.5800 USD
Sale 200 35.5638 USD
Sale 600 35.5638 USD
Sale 1,383 35.5800 USD
Sale 1,600 35.4536
Sale 3,143 35.41790964
Sale 1,267 35.42980268
Sale 900 35.45777778
Sale 3,000 35.43950333
Sale 190 35.41473684
Sale 300 35.48
Sale 637 35.65610675
Sale 600 35.456
Sale 100 35.67
Sale 100 35.75
Sale 1,122 35.11605615
Sale 100 35.455
Sale 200 35.535
Sale 100 35.17
Sale 600 35.495
Sale 100 35.456
Sale 400 35.735
Sale 300 35.58
Sale 2,750 35.48647818
Sale 300 35.596
Sale 3,240 35.58
Sale 200 35.69
Sale 300 35.5713
Sale 3,300 35.4530303
Sale 200 35.735
Sale 900 35.55855556
Sale 200 35.67
Sale 100 35.69
Sale 300 35.68666667
Sale 50 35.4635
Sale 400 35.6742
Sale 200 35.735
Sale 238 35.58
Sale 600 35.7424
(b) Derivatives transactions (other than options)
Product name, Long/Short Number of Price per
(e.g. CFD) (Note 6) Securities unit (GBP)
(c) Options transactions in respect of existing securities
(i) Writing, selling, purchasing or varying
Product name, Writing, Number of Exercise Type, e.g. Expiry Option money
e.g. call selling, securities to price American, date paid/received
option purchasing, which the option European etc. per unit (GBP)
varying etc. relates (GBP)
(ii) Exercising
Product name, e.g. Number of Exercise price per
call option securities unit (Note 5)
(d) Other dealings (including new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
4. OTHER INFORMATION
None
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the
person disclosing and any other person relating to the voting rights of
any relevant securities under any option referred to on this form or
relating to the voting rights or future acquisition or disposal of any
relevant securities to which any derivative referred to on this form is
referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) YES
Date of disclosure 01 July 2009
Contact name Geoff Smith
Telephone number 020 7116 2913
If a connected EFM, name of
offeree/offeror with which connected
If a connected EFM, state nature of
connection (Note 10)
Notes
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk
SUPPLEMENTAL FORM 8
DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1, Form 8.1(b)(ii) or Form 8.3, as appropriate)
OPEN POSITIONS (Note 1)
Product name, Written or Number of securities Exercise price Type, e.g. Expiry date
e.g. call option purchased to which the option (Note 2) American,
or derivative relates European etc.
Option Purchased -700 40.0000 AMER 16/01/2010
Option Purchased 100 25.0000 AMER 20/02/2010
Option Purchased 100 22.5000 AMER 22/01/2011
Option Purchased 100 17.5000 AMER 22/01/2011
Option Purchased 100 15.0000 AMER 16/01/2010
Option Purchased 100 12.5000 AMER 22/01/2011
Option Purchased -100 25.0000 AMER 21/11/2009
Option Purchased -100 17.5000 AMER 22/08/2009
Option Purchased -100 17.5000 AMER 16/01/2010
Option Purchased -200 35.0000 AMER 21/11/2009
Option Purchased -23,900 25.0000 AMER 22/08/2009
Option Purchased -500 20.0000 AMER 22/08/2009
Option Purchased 400 50.0000 AMER 21/11/2009
Option Purchased -700 35.0000 AMER 18/07/2009
Option Purchased -1,000 30.0000 AMER 18/07/2009
Option Purchased -1,200 30.0000 AMER 22/01/2011
Option Purchased -1,600 30.0000 AMER 21/11/2009
Option Purchased -2,000 40.0000 AMER 18/07/2009
Option Purchased -2,000 22.5000 AMER 22/08/2009
Option Purchased -2,400 25.0000 AMER 16/01/2010
Option Purchased -4,600 25.0000 AMER 16/01/2010
Option Purchased -11,100 30.0000 AMER 18/07/2009
Option Purchased -500 20.0000 AMER 22/08/2009
Option Purchased 1,900 30.0000 AMER 22/08/2009
Option Purchased 22,300 25.0000 AMER 22/08/2009
Option Purchased 8,000 35.0000 AMER 22/08/2009
Option Purchased 6,900 30.0000 AMER 16/01/2010
Option Purchased 6,400 30.0000 AMER 16/01/2010
Option Purchased 6,000 40.0000 AMER 22/08/2009
Option Purchased 4,400 35.0000 AMER 16/01/2010
Option Purchased 4,400 20.0000 AMER 16/01/2010
Option Purchased 2,900 35.0000 AMER 21/11/2009
Option Purchased 2,700 50.0000 AMER 16/01/2010
Option Purchased 100 35.0000 AMER 22/08/2009
Option Purchased 2,300 45.0000 AMER 16/01/2010
Option Purchased 200 15.0000 AMER 22/01/2011
Option Purchased 1,800 40.0000 AMER 22/01/2011
Option Purchased 1,700 30.0000 AMER 22/08/2009
Option Purchased 1,200 40.0000 AMER 21/11/2009
Option Purchased 1,100 35.0000 AMER 18/07/2009
Option Purchased 1,100 30.0000 AMER 21/11/2009
Option Purchased 1,000 55.0000 AMER 22/01/2011
Option Purchased 900 25.0000 AMER 22/01/2011
Option Purchased 900 22.5000 AMER 22/08/2009
Option Purchased 700 35.0000 AMER 16/01/2010
Option Purchased 87,900 35.0000 AMER 22/08/2009
Option Purchased 2,700 45.0000 AMER 21/11/2009
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given.
Full details of any existing agreements to purchase or to sell should also be given on this form.
2. For all prices and other monetary amounts, the currency must be stated.
For details of the Code's dealing disclosure requirements, see Rule 8 and its Notes which can be viewed on the Takeover
Panel's website at www.thetakeoverpanel.org.uk